Many vaccines are based around virus-like particles (VLPs). VLPs resemble viruses, but importantly don't carry pathogenic genetic material and thus cannot cause disease. These particles are engineered to display one part of a pathogen to the immune system, which can elicit strong protection upon any subsequent exposure to that pathogen.
Synthetic biologists use bacterial superglue for faster vaccine development
20 January 2016
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.